Makes instruments that detect protein biomarkers in blood and tissue for neurology and oncology research.
Jun 2026Revenue $153M/yrExpenses $306M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Quanterix be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $153M and expenses $306M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $139M | $264M | −$126M |
| Dec 2024 | $137M | $190M | −$52.6M |
| Dec 2023 | $122M | $168M | −$46.0M |
| Dec 2022 | $106M | $210M | −$104M |
| Dec 2021 | $111M | $167M | −$56.5M |
| Dec 2020 | $86.4M | $118M | −$31.6M |
| Dec 2019 | $56.7M | $98.3M | −$41.6M |
| Dec 2018 | $37.6M | $69.2M | −$31.6M |
| Dec 2017 | $22.9M | $48.9M | −$26.0M |
| Dec 2016 | $17.6M | $39.3M | −$21.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.